William J. McAleer
49Patents
15h-index
22Co-inventors
77Inventor score
Filing activity: Jan 30, 1974 → Oct 19, 1989
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US4337242A | Vaccine stabilizer containing L-glutamic acid and L-arginine | Emerging Cross-Sectional Technologies | 64 | Expired |
| US4018222A | Syringe containing frozen vaccine | Human Necessities | 44 | Expired |
| US4338335A | Vaccine stabilizer containing L-glutamic acid and L-arginine | Emerging Cross-Sectional Technologies | 36 | Expired |
| US4022206A | Vaccine delivery system | Human Necessities | 30 | Expired |
| US4174388A | Method for preparing hepatitis B immune globulin | Chemistry; Metallurgy | 26 | Expired |
| US4416986A | Methods of producing HBsAg | Chemistry; Metallurgy | 24 | Expired |
| US4115010A | Automated plate reader | Physics | 24 | Expired |
| US4181713A | Isolation of HB.sub.s Ag | Emerging Cross-Sectional Technologies | 23 | Expired |
| US4147772A | Vaccine stabilizer | Emerging Cross-Sectional Technologies | 22 | Expired |
| US4004981A | Cell removing device | Chemistry; Metallurgy | 20 | Expired |
| US4783407A | Growth of hepatitus A virus in vero cells | Emerging Cross-Sectional Technologies | 18 | Expired |
| US4088748A | Hepatitis B surface antigen | Chemistry; Metallurgy | 16 | Expired |
| US4273762A | Lyophilization process for live viral compositions | Chemistry; Metallurgy | 16 | Expired |
| US5024836A | Stable lyophilized live herpes virus vaccine | Chemistry; Metallurgy | 15 | Expired |
| US4742158A | Purification of hepatitis pre-S antigens by polymerized serum albumin affinity binding | Emerging Cross-Sectional Technologies | 15 | Expired |
| US4102996A | Method of preparing hepatitis B core antigen | Emerging Cross-Sectional Technologies | 15 | Expired |
| US4707542A | Immunogenic HbsAg derived from transformed yeast | Emerging Cross-Sectional Technologies | 15 | Expired |
| US3933585A | Process for production of vaccines | Chemistry; Metallurgy | 14 | Expired |
| US4024243A | Process for isolating hepatitis B antigen | Emerging Cross-Sectional Technologies | 11 | Expired |
| US4217418A | Recovery of small particles by flow centrifugation | Emerging Cross-Sectional Technologies | 11 | Expired |
| US4241175A | Assay for hepatitis B core antibody | Emerging Cross-Sectional Technologies | 11 | Expired |
| US4234564A | Hepatitis B core antigen composition | Emerging Cross-Sectional Technologies | 10 | Expired |
| US4301249A | High titer production of hepatitis A virus | Emerging Cross-Sectional Technologies | 10 | Expired |
| US3976547A | Cell and vaccine production | Chemistry; Metallurgy | 9 | Expired |
| US4329424A | Macroscopic method for determining cytopathic effects in viral assay | Chemistry; Metallurgy | 8 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.